2 studies found for:    ALVINA
Show Display Options
Rank Status Study
1 Completed Nutrition and Physical Activity in Patients With Cerebrovascular Disease
Condition: Cerebrovascular Disorders
Interventions: Dietary Supplement: Conventional diet +/- wine;   Dietary Supplement: Luxembourg variant of Mediterranean diet + physical activity +/- wine
2 Active, not recruiting
Has Results
A Multicenter Phase 2 Study of PCI-32765 (Ibrutinib) in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
Conditions: Chronic Lymphocytic Leukemia With 17p Deletion;   Small Lymphocytic Lymphoma With 17p Deletion
Intervention: Drug: PCI-32765

Indicates status has not been verified in more than two years